Access cutting-edge biliary tract cancer treatment through this clinical trial at a research site in Fullerton. Study-provided care at no cost to qualified participants.
Access biliary tract cancer specialists in Fullerton at no cost
This study follows strict safety protocols and ethical guidelines
All study-related biliary tract cancer treatment provided free
The purpose of this study is to measure the efficacy and safety of T-DXd with rilvegostomig or T-DXd monotherapy compared with gemcitabine plus cisplatin and durvalumab in patients with advanced treatment naïve HER2-expressing BTC.
Sponsor: AstraZeneca
Check if you qualify for this biliary tract cancer clinical trial in Fullerton, CA
If you're searching for biliary tract cancer treatment options in Fullerton, CA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Fullerton research site is actively enrolling participants for this clinical trial. You'll receive care from experienced biliary tract cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.